Unidade Local De Saude De Sao Jose E.P.E. — Clinical Trial Site

100 Registered trials

45 Currently recruiting

Organisation

Unidade Local De Saude De Sao Jose E.P.E.

Location

Lisbon, Portugal

Identifier

ORG-100029490

Address

Rua Jose Antonio Serrano, 1150-199, Portugal

Departments

#2463: Serviço de Neurologia
1811: Serviço Neurologia
2701; Serviço de Dermatologia
2911: Neurologia
3303: Serviço de Dermatologia
35105:Oncologia
5804: Oncologia
5804:Oncologia
7263: Neurologia
9231: Serviço de Dermatologia
Cardiology
Cardiology Department
Cardiothoracic Surgery
Centro de Responsabilidade Integrada - Medicina e Cirurgia Fetal
Centro de Responsabilidade Integrada de Esclerose Múltipla
Centro de Responsabilidade Integrado de Esclerose Múltipla da ULS São José
Centro Hospitalar de Lisboa Central (#1)
Departamento de Cardiologia Pediátrica
Departamento de Oncologia
Department of Nephrology
Dermatologia
Dermatology
Dermatology Department
Dermatovenereology
Hematologia
Hematology
Hospital de Santa Marta - Serviço de Cardiologia Pediátrica
Hospital Dona Estefânia-Serviço de Imunoalergologia
Immunoallergology
Infectious Diseases
Internal Medicine
Medical Oncology
Medical Oncology - Hospital dos Capuchos
N/A
NA
Nefrologia
Nephrology
Nephrology Department
Neurology
Neuropediatria
Oftalmologia
Ophthalmology
Opthalmic Service
Paediatric Neurology
Pediatric Cardiology
Pediatric Department
Pediatric Neurology
Pediatric Rheumatology Unit
Pediatrics
Pneumologia
Pulmonology
Serviço de Endocrinologia
Serviço de Hematologia
Serviço de Medicina Interna
Serviço de Nefrologia
Serviço de Neurologia
Serviço de Pediatria
Serviço de Pediatria Médica
Serviço de Pneumologia
Serviço Neurologia
Unidade de Ensaios Clínicos - Centro de Investigação
Unidade de Neonatologia da área de Pediatria (Maternidade Dr. Alfredo da Costa)
Unidade Local de Saúde São José
Unidade Local Saude de Sao Jose - Hospital Sao Jose
Urology

Clinical trials at this site (100)

Search interface

TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting

2024-519917-72-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-10-29
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hid… Recruiting

2025-520564-17-00 Hidradenitis suppurativa (HS) 5 2025-10-16
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Efficacy and safety of remibrutinib after switching from ocrelizumab in participants living with relapsing multiple sclerosis, followed by o… Recruiting

2023-509275-17-00 Relapsing multiple sclerosis 5 2025-10-06
A study to evaluate the efficacy and safety of ruxolitinib cream in children (6 to <12 years old) with non-segmental vitiligo Recruiting

2024-513171-41-00 Vitiligo 5 2025-09-11
A phase IV, multicentre, open-label, single-arm study to investigate the efficacy, safety and durability of faricimab (RO6867461) in caucasi… Recruiting

2024-515640-22-00 polypoidal choroidal vasculopathy 6 2025-08-06
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Recruiting

2024-520154-38-00 Acute Myeloid Luekemia 5 2025-07-29
Phase 3 Study of Ravulizumab versus Placebo in Adult Participants at High Risk of DGF after Kidney Transplantation (AWAKE) Recruiting

2024-517568-48-00 Delayed Graft Function after Kidney Transplantation 5 2025-07-21
A study to test whether spesolimab helps people with a skin condition called pyoderma gangrenosum Recruiting

2024-514306-31-00 Pyoderma gangrenosum 5 2025-02-13
A study describing the efficacy and safety of belimumab administered subcutaneously in adult participants with early systemic lupus erythema… Recruiting

2023-509146-35-00 Systemic Lupus Erythematosus 6 2025-01-30
A study to evaluate the efficacy and safety of frexalimab, brivekimig or rilzabrutinib in participants aged 16 to 75 years with primary foca… Recruiting

2024-511775-15-00 Immune system diseases 4 2025-01-17
A study to test the efficacy and safety of riliprubart against the usual treatment of intravenous immunoglobulin (IVIg) in people with chron… Recruiting

2023-508338-33-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2024-10-01
HepaGrowth Recruiting

2024-516572-15-00 Fetal Growth Restriction 6 2024-09-16
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A study to test the effects and safety of riliprubart in people with chronic inflammatory demyelinating polyneuropathy (CIDP) for which the … Recruiting

2023-506503-26-00 Polyneuropathy, Inflammatory Demyelinating, Chronic 5 2024-07-31
A study evaluating the safety and efficacy of an experimental drug for chronic lung disease against normally prescribed care in extremely pr… Recruiting

2024-515914-41-00 Chronic Lung Disease 4 2024-07-05
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting

2023-503631-18-01 Nervous system diseases 5 2024-05-20
Hidradenitis Suppurativa: Evaluation of Upadacitinib in Adult and Adolescent Subjects Recruiting

2023-503661-28-00 Hidradenitis Suppurativa 5 2023-10-26
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Resectable, Early-stage (II to IIIB) Non-small Cell Lun 4 2022-06-10
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo… Recruiting

2023-508963-58-00 Symptomatic hypertrophic cardiomyopathy (HCM) 4 2022-01-31
Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical tria… Recruiting

2023-509290-22-00 Severe Symptomatic Aortic Stenosis 6 2022-01-21
HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting

2024-516728-32-00 Indolent Systemic Mastocytosis and SSM 10 2021-10-29
A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 following Intravenous a… Recruiting

2023-509357-31-00 Multiple Sclerosis (MS) 1 2021-06-01
Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting

2023-508956-20-00 Hidradenitis suppurativa 5 2020-03-12